Gliflozins beat other T2DM drugs for lowering kidney stone risk: study
For adults with type 2 diabetes, initiation of SGLT2 inhibitors may lower the risk for nephrolithiasis, according to a US study in JAMA Internal Medicine.…
Article Type: Specialist Update
Doctors call for inquiry into rising perinatal deaths
A leading obstetrician is calling for a national inquiry into maternity care after new data revealed the perinatal death rate in Queensland had jumped by…
‘Lack of scientific rigour’: Journal retracts studies cited in US medical abortion access case
Two studies that warned of the harms of medical abortion have been retracted by the journal’s publisher over flaws in the data and conflicts of…
Secondary primary malignancies ‘rare’ after CAR T-cell immunotherapy
The incidence of secondary primary malignancy after anti-CD19 chimeric antigen receptor T-cell immunotherapy is very low, according to a study in Nature Medicine. US researchers…
Offer compression sleeves to prevent breast cancer–related arm lymphoedema: new guidance
Patients at risk of developing arm lymphoedema after breast cancer treatment should be offered prophylactic compression sleeves, according to world-first guidance. Axillary reverse mapping and…
‘We did not expect these results’: Testosterone therapy linked to higher fracture risk
Testosterone treatment may increase fracture risk in middle-aged and older men with hypogonadism, according to new research that contradicts conventional wisdom. While exogenous testosterone has…
Alpha therapy a ‘viable option’ for metastatic castration-resistant prostate cancer
Targeted alpha therapy is safe and effective for treating metastatic castration-resistant prostate cancer when other anticancer agents have failed, show results from the largest trial…
Chemotherapy plus dose-escalated radiation shows promise for advanced NSCLC: study
Chemoradiation with an adaptive stereotactic ablative radiotherapy boost is safe and effective for patients with locally advanced, unresectable non-small cell lung cancer, according to a…
FDA investigates secondary malignancy risk with CAR T-cell therapy
The TGA is closely watching an overseas investigation of chimeric antigen receptor T-cell therapies after reports of secondary malignancies in treated patients. Last month, the…
Isthmocele, not prior C-section, lowers IVF success rate: study
Isthmocele formation after a previous caesarean section — rather than the C-section itself — lowers the odds of a live birth in women undergoing IVF,…
